Contamination of peripheral blood by monoclonal B cells following treatment of multiple myeloma by high‐dose chemotherapy
- 1 October 1993
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 85 (2) , 411-412
- https://doi.org/10.1111/j.1365-2141.1993.tb03188.x
Abstract
Summary Peripheral blood samples obtained from five patients with multiple myeloma, after high‐dose chemotherapy, were studied for monoclonal B plasma cell contamination. We used the technique of immunoglobulin heavy chain gene ‘fingerprinting’ at the time of diagnosis and during apheresis. The level of sensitivity of this technique is between 041% and 0.001% in two patients in whom a monoclonal population was detected in peripheral blood.Keywords
This publication has 3 references indexed in Scilit:
- High-dose chemoradiotherapy and autologous blood stem cell transplantation in multiple myeloma: results of a phase II trial involving 63 patientsBlood, 1993
- Immunoglobulin gene ‘fingerprinting’: an approach to analysis of B lymphoid clonality in lymphoproliferative disordersBritish Journal of Haematology, 1991
- Newer approaches to the therapy of multiple myeloma [editorial]Blood, 1990